Staff Product Manager - Software at HeartFlow

San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Technology, Healthcare, CardiologyIndustries

Requirements

Proven track record as a product manager, with significant experience in managing FDA-regulated software products
Strong technical communication, stakeholder management, strategic thinking, and data-driven decision-making skills
Deep understanding of relevant medical algorithm development, validation, and performance
Strong appreciation for visual design, usability, and maintaining a high bar for design excellence
Demonstrated ability to mentor peers, lead teams, and drive strategic initiatives
Deep passion for understanding customer needs and translating them into effective products
Deep, specific experience in a subset of fields including cardiovascular anatomy, multimodal risk assessment, disease pathogenesis, computational fluid dynamics, and general understanding of medical algorithm development, validation, and performance per FDA regulations

Responsibilities

Define requirements and drive the development of clinical-grade medical algorithms, ensuring they meet FDA verification, validation and clinical performance and usability standards
Define user needs and product requirements, contribute to feature roadmaps, and align business and technical strategies
Work closely with UX design, engineering, human factors engineering, marketing, Customer Support, Clinical, QA/RA, and other teams to ensure cohesive product development and delivery
Conduct market and competitive research, gather customer insights, and analyze product usage data to inform product decisions and roadmap
Collaborate in sprint planning, oversee product development processes, and ensure high-quality delivery of features and solutions
Lead strategic initiatives and special projects that require cross-team collaboration and integration
Assist in ensuring product compliance with regulatory standards and requirements and post market surveillance activities
Contribute to the development and refinement of product development, operations, backlog management, and other collaborative processes and tools

Skills

Product Management

Medical Algorithms

Cardiovascular Anatomy

Computational Fluid Dynamics

FDA Regulations

Algorithm Validation

Clinical Imaging

Risk Assessment

Disease Pathogenesis

3D Modeling

AI Development

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free